BiotechTube
Home/Stealth BioTherapeutics/Reenie McCarthy
RM

Reenie McCarthy

Chief Executive Officer

Stealth BioTherapeutics

Therapeutic Areas

Mitochondrial DiseasesOphthalmologyRare Disease

Stealth BioTherapeutics Pipeline

DrugIndicationPhase
FORZINITY (elamipretide injection)Barth SyndromeApproved
elamipretide (ophthalmic)Dry Age-Related Macular DegenerationPhase 3